v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue $ 1,524,000 $ 1,052,000 $ 3,532,000 $ 5,116,000
Cost of revenue 1,283,000 1,099,000 3,483,000 3,981,000
Gross profit (loss) 241,000 (47,000) 49,000 1,135,000
Operating expenses:        
Research and development 884,000 1,449,000 3,745,000 6,831,000
Selling, general and administrative 2,761,000 5,032,000 10,476,000 17,188,000
Restructuring costs 742,000
Total operating expenses 3,645,000 6,481,000 14,221,000 24,761,000
Loss from operations (3,404,000) (6,528,000) (14,172,000) (23,626,000)
Modification of Series A and B warrants (1,838,000)
Interest expense, net (235,000) (1,209,000) (668,000) (3,519,000)
Other expense, net (41,000) (51,000) (159,000) (133,000)
Net loss from consolidated companies (3,680,000) (7,788,000) (16,837,000) (27,278,000)
Loss from minority interest in limited liability company (55,000) (168,000) (323,000) (431,000)
Comprehensive and net loss (3,735,000) (7,956,000) (17,160,000) (27,709,000)
Series B convertible preferred stock dividends (1,053,000) (3,064,000)
Net loss attributable to common stockholders $ (4,788,000) $ (7,956,000) $ (20,224,000) $ (27,709,000)
Net loss per share of common stock:        
Basic and diluted (in dollars per share) $ (0.26) $ (13.51) $ (1.47) $ (54.73)
Weighted average shares used in computing net loss per common share:        
Basic and diluted (in shares) 18,079,200 588,976 13,747,913 506,329

Source